Signia Pure C&G BCT IX vs Sony CRE-C20

The Signia Pure C&G BCT IX is a premium prescription behind-the-ear hearing aid released in 2025, priced at $3,398. In our lab testing, it earned an A grade with a SoundScore of 4.4/5, placing it in the top 39% of the 36 prescription hearing aids we've tested. This device shows notable strengths in speech clarity and own-voice comfort. Speech in quiet scored 3.8/5, which is 0.47 points above the category average—a solid result for everyday conversations. Speech in noise measured 2.5/5, above the category average by 0.58 points, though only mixed in absolute terms, meaning challenging listening environments may still present difficulty. Own-voice comfort is a standout at 3.8/5, a full 1.05 points above average, suggesting reduced occlusion effects that many wearers find bothersome. Feedback handling scored 4.2/5—strong in absolute terms, though 0.51 points below the category average of 4.71/5. Music streaming at 2.7/5 is essentially on par with category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Consumers shopping in this premium price tier should note that several alternatives offer higher overall scores, including the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5). For those prioritizing own-voice comfort and solid speech performance in quieter settings, the Pure C&G BCT IX delivers, but buyers seeking top-tier noise performance may want to compare options.

The Sony CRE-C20 is an invisible-in-ear OTC hearing aid priced at $999, earning a B grade with a SoundScore of 3.6/5 in our lab testing. This mid-priced device offers a discreet form factor with rechargeable batteries, positioning it in the upper tier of the OTC market. In our testing, the CRE-C20 demonstrates notable strengths in speech clarity. Speech in quiet scores 4.1/5—a strong result that sits 1.33 points above the OTC category average. Speech in noise performance reaches 2.7/5, which is 1.24 points above the category average, though only mixed in absolute terms. Own voice comfort scores 2.9/5, slightly above average for the category at +0.39 points. The device shows significant limitations in other areas. Music streaming scored 0.0/5, falling 1.92 points below the category average—this invisible-in-ear design does not support audio streaming functionality. Feedback handling registers at 3.9/5, which is solid in absolute terms, though 0.64 points below the category average of 4.54/5. The CRE-C20 demonstrates meaningful improvement with proper adjustment. The normalized Initial Score of 3.4/5 improves to 4.2/5 when tuned, suggesting users who invest time in optimization will see better results. Within its price range, alternatives like the Sony CRE-E10 (4.69/5) and Lexie B2 Plus (4.43/5) score higher overall. The CRE-C20 is best suited for users prioritizing discretion and speech clarity who don't need music streaming capabilities.